Invivyd (IVVD) Current Assets (2020 - 2025)
Invivyd (IVVD) posted Current Assets of $247.5 million for Q4 2025, up 125.44% on a QoQ basis from $109.8 million in Q3 2025, and up 145.79% year-over-year from $100.7 million in Q4 2024.
Invivyd (IVVD) Current Assets (2020 - 2025) Analysis & Trends
Invivyd's Current Assets history runs 6 years deep, the most recent figure standing at $247.5 million for Q4 2025.
- Quarterly Current Assets rose 145.79% year-over-year to $247.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $247.5 million (up 145.79% YoY) and the FY2025 annual result came in at $247.5 million, up 145.79% from the prior year.
- Current Assets was $247.5 million for Q4 2025 at Invivyd, up from $109.8 million in the prior quarter.
- Across five years, Current Assets topped out at $680.2 million in Q3 2021 and bottomed at $59.3 million in Q2 2025.
- A 5-year average of $305.5 million and a median of $270.1 million in 2023 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2021 — Current Assets soared 425.39% — and 2025, when it tumbled 65.74%.
- Invivyd's Current Assets stood at $616.7 million in 2021, then plunged by 38.88% to $376.9 million in 2022, then plunged by 40.34% to $224.9 million in 2023, then slumped by 55.23% to $100.7 million in 2024, then surged by 145.79% to $247.5 million in 2025.
- Business Quant data shows IVVD's Current Assets at $247.5 million in Q4 2025, $109.8 million in Q3 2025, and $59.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 73.04 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 3.59 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 6.60 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 1.97 Bn |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn | 247.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 247.47 Mn |
| Sep 30, 2025 | 109.77 Mn |
| Jun 30, 2025 | 59.28 Mn |
| Mar 31, 2025 | 75.83 Mn |
| Dec 31, 2024 | 100.68 Mn |
| Sep 30, 2024 | 151.10 Mn |
| Jun 30, 2024 | 173.01 Mn |
| Mar 31, 2024 | 209.88 Mn |
| Dec 31, 2023 | 224.88 Mn |
| Sep 30, 2023 | 270.10 Mn |
| Jun 30, 2023 | 309.99 Mn |
| Mar 31, 2023 | 344.62 Mn |
| Dec 31, 2022 | 376.92 Mn |
| Sep 30, 2022 | 421.60 Mn |
| Jun 30, 2022 | 481.36 Mn |
| Mar 31, 2022 | 554.30 Mn |
| Dec 31, 2021 | 616.71 Mn |
| Sep 30, 2021 | 680.16 Mn |
| Jun 30, 2021 | 396.06 Mn |
| Dec 31, 2020 | 117.38 Mn |